10.2337/dc19-S009 73
First introduced as a treatment for Type 2 diabetes and now pursued as a blockbuster weight management therapy, GLP-1 receptor agonists (GLP-1 RAs) have ignited a global scale-up effort that is reshaping the drug manufacturing landscape
The Benefits of a GLP 1 Wisconsin Telehealth Program A virtual GLP 1 Wisconsin program offers unparalleled benefits, making it an excellent choice for those seeking a sustainable weight loss Wisconsin solution: Appetite Control and Reduced Cravings: Wegovy and Zepbound work to signal to your brain that you are full, significantly reducing hunger and those intense cravings that often derail attempts to Chicago lose weight winter
A 42-year-old female with longstanding profound fatigue, chronic pain, asthma, multiple food intolerances, GI symptoms including diarrhea, urticaria, food cravings, weight gain, and migraine who was essentially housebound due to constant exhaustion (she estimated 30% of normal energy) took tirzepitide at 3.75 mg principally to address obesity
GLP-1 drugs also influence the release of hormones that regulate sleep and wakefulness
Published in the June 2023 issue of the journal JCI Insight, the study adds to growing preclinical evidence that the glucagon-like peptide-1 (GLP-1) system plays a role in alcohol and other substance use disorders, and that GLP-1 receptor agonists show potential for treating people with alcohol use disorder (AUD)
